PARIS® Test
The PARIS® Test is the antidote for today's failing standard of care. DNA sequencing alone predicts effective treatment an estimated 15% of the time. The PARIS® Test delivers effective treatment options for solid tumors up to 80% of the time, based on recent testing. As a CLIA-certified lab, SEngine is the only lab which provides actionable reports directly to oncologists today.